ConcertAI is set to showcase its latest advancements in multimodal and real-world data management at the American Society of Clinical Oncology (ASCO) annual meeting. This year, the spotlight will be on Cara AI and the TeraRecon Oncology Suite, two innovative tools designed to enhance research capabilities and streamline complex clinical workflows.
Cara AI stands out for its ability to integrate radiological imaging studies, digital pathology, and both structured and unstructured real-world data (RWD). This platform offers an open AI framework that allows researchers to incorporate and manage AI algorithms from...